WAGENINGEN, The Netherlands–(BUSINESS WIRE)–Dutch health ingredients innovator, NutriLeads, announces the first peer-reviewed publication of data proving the immune modulating properties of its proprietary pectin-derived rhamnogalacturonan-I (RG-I) polysaccharides in the journal Nutrients.
RG-I are natural, plant-derived compounds (polysaccharides), that interact with the gut bacteria (microbiota) and the host innate immune system. In selected traditional plant extracts, such pectic polysaccharides have previously been shown to have immunostimulatory effects. However, these traditional remedies are often expensive, derived from non-renewable sources, and could face regulatory challenges.
In this recent publication, NutriLeads shows that RG-I can be extracted from affordable and renewable crops, namely carrots and bell peppers, and even obtained from side streams of crop processing, allowing for sustainable and scalable production. RG-I from both carrot and bell pepper showed immune stimulating and microbiota modulating activity in vitro. Furthermore, bell pepper RG-I was shown to enhance innate immune responsiveness in a proof-of-concept trial in humans.
Commenting on the publication and the expected impact of the findings, Ruud Albers, PhD, CEO of NutriLeads, said: “We are delighted to share these new data, demonstrating the immunomodulatory effects of plant-based RG-I, which have the potential to bring health benefits to us all. We are particularly pleased that we can successfully derive RG-I from sustainable and widely available sources.
“Due to the pandemic, immune health is even higher on the agenda than ever before, and we believe that this research shows that dietary supplementation with RG-I from specific food crops is ideally suited to support immune function and modulate the microbiota. We are well advanced with generating additional evidence showing the immune benefits of carrot-derived RG-I and are working together with Food and Food Supplement companies to deliver these benefits to consumers in the second half of 2021.”
Demand for food supplements and food and beverage products with immune health properties has been growing sharply in recent years. The global immune health supplements market alone was estimated to be worth USD 16.32 billion in 2019 and is expected to reach USD 29.40 billion by 2027. In addition, recent research shows that 64% of respondents will aim to improve their immunity in the next 12 months.
NutriLeads’ lead ingredient, BeniCaros, extracted from carrot pomace (a side stream from carrot juice production), has been developed to support immune function. This ingredient is expected to be available in the US for the formulation of dietary supplements and functional foods in the second half of 2021.
2. Early access article available at: https://www.mdpi.com/2072-6643/13/3/963
4. FMCG Gurus, Top Ten Trends for 2021, Dec 2020. https://fmcggurus.com/webinar-top-ten-trends-2021/
– ENDS –
Notes to Editors:
NutriLeads, established in 2012, is a Health Ingredients Innovator advancing nutrition to strengthen human health. Based on our proprietary RG-I platform, we are developing a portfolio of sustainable and 100% natural, plant-based ingredients that are clinically proven to support human physiology and modulate the gut microbiome.
NutriLeads takes all its proprietary ingredients through clinical trials to demonstrate their positive effect on human health (e.g. immune health, gut health and metabolic health), gains regulatory approval for market access, commissions production, and then partners with companies that incorporate the ingredients into their finished (food) products to bring the benefits to consumers.
The Company’s lead RG-I-based ingredient, BeniCaros, supports immune function. The ingredient, which is extracted from carrots, is expected to be available in the US for the formulation of dietary supplements and functional foods in the second half of 2021.
NutriLeads is privately held and backed by investors including Icos Capital, Goeie Grutten, DSM Venturing, Oost NL, SHIFT Invest and Thuja Capital. It has also received non-dilutive funding from various regional, national and European grants, including Eurostars, EFRO and SME instrument.
The Company is headquartered in Wageningen, the Netherlands, a world-renowned centre for nutrition and health research and development, also known as the ‘Foodvalley’.
For more information, please visit the website: www.nutrileads.com